
    
      The aim of this substudy of MARCH is to characterize the changes in protein and salt
      excretion through the kidney utilising the randomised arms of the parent study MARCH. The
      investigators hypothesize there will be an improvement in proteinuria in those switching to
      maraviroc containing regimens.
    
  